این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Craniomaxillofacial Research، جلد ۱۲، شماره ۲، صفحات ۸۶-۹۲
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Comparing the Expression Levels of GCG and FBN-1 in the Plasma of Patients with Basal Cell Carcinoma (BCC) and Healthy Individuals
چکیده انگلیسی مقاله Introduction: One of the most common types of skin cancer is basal cell carcinoma (BCC), which puts a big burden on the healthcare system. Direct and dermoscopic examinations are used to diagnose basal cell carcinoma. GCG is a protein-coding gene expressed in various cells throughout the body, including the small intestine, brain, and skin. Fibrillin-1 is an extracellular protein found in many body tissues. In this study, we compare the expression of GCG and FBN1 genes in the blood of patients with BCC and a healthy control group. Materials and Methods: 1. Selection of patients and sampling. 2. Blood sampling of BCC patients and the control group. 3. Isolation of RNA from blood using an extraction kit. 4. Measurement of RNA concentration and purity. 5. cDNA synthesis and real-time PCR using a specific miRNA cDNA synthesis kit. 6. Statistical analysis Results: The GCG biomarker was positive in 9 out of 15 patients in the group of patients with basal cell carcinoma (BCC). The rate of positivity for this biomarker in the group of healthy individuals was 4 out of 15, indicating a statistically significant difference between the two groups (P-value<0.001). The FBN1 biomarker was positive in 11 out of 15 patients with basal cell carcinoma (BCC). The rate of positivity for this biomarker in the group of healthy individuals was 5 out of 15 people, indicating a statistically significant difference between the two studied groups. (P-value<0.001).  Conclusion: The expression of GCG and FBN1 is significantly higher in patients with BCC compared to healthy individuals. Further studies can be done to ensure the role of these genes in the diagnosis of skin cancers.  Keywords: Basal cell carcinoma; Glucagon gene (GCC); Fibrillin-1 (FBN-1); MicroRNA. 
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Maryam Keyfari Alamdari
Students&#x2019; Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.


| Abdolreza Mohamadnia
Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran, And Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.


| Mohammad Bayat
Department of Oral and Maxillofacial Surgery, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran; Craniomaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran.


| Masoume Farhangiyan
Craniomaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran.


| Naghmeh Bahrami
Craniomaxillofacial Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
نشانی اینترنتی https://jcr.tums.ac.ir/index.php/jcr/article/view/553
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات